Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001047469-13-004011
Filing Date
2013-04-05
Accepted
2013-04-05 13:27:53
Documents
6
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a2214096z10-ka.htm 10-K/A 1185504
2 EX-23.1 a2213529zex-23_1.htm EX-23.1 3449
3 EX-31.1 a2213529zex-31_1.htm EX-31.1 7372
4 EX-31.2 a2213529zex-31_2.htm EX-31.2 7358
5 EX-32.1 a2213529zex-32_1.htm EX-32.1 4712
6 EX-32.2 a2213529zex-32_2.htm EX-32.2 4698
  Complete submission text file 0001047469-13-004011.txt   1214073
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 937-6100
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35565 | Film No.: 13745259
SIC: 2834 Pharmaceutical Preparations